EVGN:NASDAQ
Evogene Ltd
$0.58
arrow_downward
-1.82%(-0.011) 1D
Jun 11, 3:03:51 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EVGN...
Open
$0.58
High
$0.60
Low
$0.57
Mkt. cap
5.08M
Avg. vol.
974.30K
Volume
109.31K
52-wk high
$1.63
52-wk low
$0.52
EPS
-$1.38
Beta
1.35
Shares outstanding
10.41M
No. of employees
52
Open
$0.58
High
$0.60
Low
$0.57
Mkt. cap
5.08M
Avg. vol.
974.30K
Volume
109.31K
52-wk high
$1.63
52-wk low
$0.52
EPS
-$1.38
Beta
1.35
Shares outstanding
10.41M
No. of employees
52
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to EVGN in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for EVGN in the last 3 months.
Highest
Current $0.58
$2.15 (+269.92%)
Average
$2.15 (+269.92%)
Lowest
$2.15 (+269.92%)
News stories
From sources across the web
Benzinga
·
8 hours ago
Full Transcript: Evogene Q1 2026 Earnings Call
Profile
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
About Evogene Ltd
AI content may include mistakes. Learn more